Insulin Sensitizer
Update given on Sucanon regulatory approval, production in Mexico
Published in Medical Letter on the CDC and FDA, November 16th, 2003
"Our licensee has indicated to us that our file is in queue for receipt of the final signature. Responsible parties at the Board of Health have been out of Mexico; they have now returned. Our licensee's office is in regular contact with the Board of Health in Mexico City and the final required signature is expected shortly," Rieveley said.
"We project that our first order from Mexico will be in the range of one million Sucanon tablets. We are currently preparing for production of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Smallpox
Orthopoxviruses detected using microarrays of immobilized oligonucleotides - Vaccine Development
Simultaneous measurement of pneumococcal polysaccharide antibodies reported - Antimicrobials
Antibiotic management program causes pseudo-outbreak of nosocomial infections - Drug Resistance
Multidrug-resistant Neisseria gonorrhoeae reported in Hawaii - Tobacco Use
Five tobacco-specific nitrosamines in cigarette smoke quantified - Addiction Medicine
Cost and noncompliance contribute to U.S. physicians' low use of naltrexone - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
